540222:BOM
Laurus Labs Ltd
၂,၀၇၀.၀၀ ₹
arrow_upward
+၀.၅၃%(+၁၁.၀၀) 1D
အောက် ၁၉, GMT+၅:၃၀ ၁၀:၅၃:၃၅ · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 540222...
Open
၂,၀၆၄.၀၀ ₹
High
၂,၀၈၇.၀၀ ₹
Low
၂,၀၅၅.၂၀ ₹
Mkt. cap
ဋေ ၁.၁၂ သိန်း
Avg. vol.
၈.၈၁ သောင်း
Volume
၁.၅၂ သောင်း
Dividend
၀.၁၀%
Quarterly dividend
၀.၅၀ ₹
Ex-dividend date
၂၀၂၆ မေ ၈
P/E ratio
၁၀၂.၃၅
52-wk high
၂,၀၈၇.၀၀ ₹
52-wk low
၉၀၁.၈၅ ₹
EPS
၂၀.၂၃ ₹
Shares outstanding
၁၀.၆၄ ကုဋေ
No. of employees
၇ ထောင်
Open
၂,၀၆၄.၀၀ ₹
High
၂,၀၈၇.၀၀ ₹
Low
၂,၀၅၅.၂၀ ₹
Mkt. cap
ဋေ ၁.၁၂ သိန်း
Avg. vol.
၈.၈၁ သောင်း
Volume
၁.၅၂ သောင်း
Dividend
၀.၁၀%
Quarterly dividend
၀.၅၀ ₹
Ex-dividend date
၂၀၂၆ မေ ၈
P/E ratio
၁၀၂.၃၅
52-wk high
၂,၀၈၇.၀၀ ₹
52-wk low
၉၀၁.၈၅ ₹
EPS
၂၀.၂၃ ₹
Shares outstanding
၁၀.၆၄ ကုဋေ
No. of employees
၇ ထောင်
News stories
From web sources and news partners
The Economic Times
·
ပြီးခဲ့သည့် ၂ ရက်
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd